Publications by authors named "Mahdi Behdani"

Claim this Profile
E
Enhanced immunogenicity of COVID-19 RBD fused to mutant scorpion's phospholipase D for vaccine development.
Mohammad-Reza Zareinejad, Mahdi Behdani, Mohammad Taghi Goodarzi, Akbar Oghalaie, Mohammad Hosseininejad-Chafi

New Microbes New Infect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of lentiviral vectors gene delivery against VEGFR2 expressing cells by co-display of the binding and fusogenic moieties: a two molecules targeting approach.
Roshanak Ahani, Mohammad Hossein Etemadzadeh, Nasir Mohajel, Mahdi Behdani, Reza Ahangari Cohan

Virol J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Characterization of an Anti-PD-L1 Immunotoxin for Targeted Cancer Therapy.
Ali Takhteh, Mohammad Hosseininejad-Chafi, Akbar Oghalaie, Mahdi Behdani, Fatemeh Kazemi-Lomedasht

Curr Pharm Biotechnol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanobody-functionalized liposomal doxorubicin: A novel strategy for angiogenesis suppression via VEGFR2 targeting.
Aezam Akbari, Azadeh Ghaffari, Fahimeh Haji-Ahmadi, Vahideh Farzam Rad, Mahdi Behdani

Bioimpacts· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Encapsulation of anti-VEGF nanobody into niosome nanoparticles: a novel approach to enhance circulation half life and efficacy.
Mohsen Chiani, Raha Abedini, Reza Ahangari-Cohan, Mahdi Behdani, Seyed Mahmoud Barzi

J Microencapsul· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanobodies as innovative immune checkpoint modulators: advancing cancer immunotherapy.
Mohammad Hosseininejad-Chafi, Zohre Eftekhari, Akbar Oghalaie, Mahdi Behdani, Nazli Sotoudeh

Med Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into the Evolutionary Dynamics: Characterization of Disintegrin and Metalloproteinase Proteins in the Venom Gland Transcriptome of the Scorpion.
Abbas Rami, Benjamin Damizadeh, Mahdi Behdani, Fatemeh Kazemi-Lomedasht

Protein Pept Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and characterization of nanobody against envenomation by Naja naja oxiana.
Akbar Oghalaie, Mohammad Hosseininejad-Chafi, Hiba Mejri, Mohammad Reza Zareinejad, Balkiss Bouhaouala-Zahar, Mahdi Behdani

Toxicon· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel SARS-COV2 poly epitope phage-based candidate vaccine and its immunogenicity.
Sharareh Mohammad Hasani, Mahdi Behdani, Zohreh Amirkhani, Ilnaz Rahimmanesh, Mahsa Esmaeilifallah

Res Pharm Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and purification of SARS-CoV-2 receptor binding domain in for diagnostic and therapeutic purposes.
Hajarossadat Ghaderi, Alireza Shoari, Shima Salehi, Ayda Hassanzadeh Eskafi, Mahdi Habibi-Anbouhi, Mahdi Behdani

Res Pharm Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in immunotoxin engineering: precision therapeutic strategies in modern oncology.
Akbar Oghalaie, Mahmoud Eshagh Hosseini, Mohammad Hosseininejad-Chafi, Zohre Eftekhari, Mahdi Behdani

Med Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications.
Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, Tahereh Ebrahimi, Fatemeh Sadat Shariati, Mahdi Behdani

Mol Ther Nucleic Acids· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropilin-1 Binding Peptide as Fusion to Diphtheria Toxin Induces Apoptosis in Non-small Cell Lung Cancer Cell Line.
Sara Eghtedari, Mahdi Behdani, Fatemeh Kazemi-Lomedasht

Curr Pharm Des· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Delivery of Diphtheria Toxin into VEGFR1/VEGFR2 Overexpressing Cells Induces Anti-angiogenesis Activity.
Fatemeh Kazemi-Lomedasht, Farzad Taghizadeh-Hesary, Zahra Faal, Mahdi Behdani

Curr Protein Pept Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTXP, The Major Cobra Toxin Peptide from Venom; A Promising Target for Antivenom Agent Development.
Mohammad Hosseininejad Chafi, Mohsen Eslamnezhad-Namin, Mansoureh Shahbazi Dastjerdeh, Mohammad Reza Zareinejad, Akbar Oghalaie, Mahdi Behdani

Curr Protein Pept Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Targeting of Zinc Transporter LIV-1 with Immunocytokine Containing Anti-LIV-1 VHH and Human IL-2 and Evaluation of its Antitumor Activity.
Rada Dehghan, Arezoo Beig Parikhani, Reza Ahangari Cohan, Mohammad Ali Shokrgozar, Esmat Mirabzadeh, Mahdi Behdani

Curr Pharm Des· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems.
Mir Salar Kazemi, Alireza Shoari, Neda Salehibakhsh, Hooman Aghamirza Moghim Aliabadi, Mohammad Abolhosseini, Mahdi Behdani

Int J Pharm· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly in vitro anti-cancer activity of melittin-loaded niosomes on non-small cell lung cancer cells.
Pooyan Honari, Delavar Shahbazzadeh, Mahdi Behdani, Kamran Pooshang Bagheri

Toxicon· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and characterization of a camelid single domain anti-CD22 antibody conjugated to DM1.
Vahab Ziaei, Alireza Ghassempour, Fatemeh Davami, Bahareh Azarian, Mahdi Behdani

Mol Cell Biochem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of human fibroblast growth factor receptor 2 by a novel specific nanobody.
Mahboubeh Irani, Mahdi Habibi-Anbouhi, Mahdi Behdani, Fatemeh Kazemi-Lomedasht

Prep Biochem Biotechnol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic.
Arezoo Beig Parikhani, Rada Dehghan, Yeganeh Talebkhan, Elham Bayat, Alireza Biglari, Mahdi Behdani

AMB Express· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell.
Fatemeh Hajari Taheri, Mahmoud Hassani, Zahra Sharifzadeh, Mahdi Behdani, Shahryar Abdoli

BMC Biotechnol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Functional Nanobody Targeting Programmed Cell Death Protein-1 as Immune Checkpoint Inhibitor.
Mohammad Hosseininejad-Chafi, Zahra Kianmehr, Kamran Pooshang-Bagheri, Fatemeh Kazemi-Lomedasht, Mahdi Behdani

Curr Pharm Des· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of polyclonal heavy chain antibodies targeting programmed death ligand-1.
Akbar Oghalaie, Alireza Shoari, Fatemeh Kazemi-Lomedasht, Fatemeh Rahimi-Jamnani, Fereidoun Mahboudi, Mahdi Behdani

Vet Res Forum· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient Inhibition of Pathologic Angiogenesis using Combination Therapy of Anti-Epcam and Anti-VEGFR2 Nanobodies.
Elmira Karami, Parisa Azizi, Mahdi Behdani, Fatemeh Kazemi-Lomedasht

Curr Pharm Des· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis